Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McLaughlin, K.
Right arrow Articles by Boulton-Jones, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLaughlin, K.
Right arrow Articles by Boulton-Jones, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 7 1696-1701, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Has the prognosis for patients with pauci-immune necrotizing glomerulonephritis improved?

K McLaughlin, P Jerimiah, J Fox, R Mactier, K Simpson and J Boulton-Jones
Renal Unit, Royal Infirmary and Renal Unit, Stobhill Hospital, Glasgow, UK; Corresponding author at: University Hospital, 339 Windermere Road, London, Ontario N6A 5A5, Canada

Background: Over the past 14 years, important advances have been made in diagnosis and treatment of patients with pauci-immune necrotizing glomerulonephritis (PINGN). The present study set out to evaluate the impact of these advances on prognosis by comparing patient survival during the period 1985-1995 with previously reported results for such patients between 1975 and 1982. Method: A retrospective analysis was carried out at two affiliated inner-city renal units on all patients considered to have PINGN during the period 1985-1995. Details of renal and extra-renal disease at presentation and during follow-up, along with treatment regimes, were noted. Figures for renal and patient survival were compared with those previously reported from one of these units. Results: A total of 47 patients were diagnosed over the period 1985-1995, with a median age of 57 years. The overall patient survival (±standard error) at 1 and 5 years was 72.3 (±0.06) and 51.2% (±0.12) respectively, with corresponding renal survival (alive and independent of renal replacement therapy) at these times of 61.7 (±0.07) and 49.9% (±0.09) respectively. We identified increased age at presentation and advanced renal failure (requiring dialysis or serum creatinine >300 &mgr;mol/l) as predictors of reduced patient and renal survival. When comparing our results with those previously reported (1975-1982), we found no improvement in prognosis for patients with PINGN during the latter period. Conclusions: These results suggest that the prognosis for patients with PINGN has not improved despite diagnostic and therapeutic advances. Delay in diagnosis and treatment may compromise the therapeutic potential in PINGN. Key words: ANCA; pauci-immune necrotizing glomerulonephritis; rapidly progressive glomerulonephritis
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. A.F. de Lind van Wijngaarden, H. A. Hauer, R. Wolterbeek, D. R.W. Jayne, G. Gaskin, N. Rasmussen, L.-H. Noel, F. Ferrario, R. Waldherr, J. A. Bruijn, et al.
Chances of Renal Recovery for Dialysis-Dependent ANCA-Associated Glomerulonephritis
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2189 - 2197.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.